AnPac Bio-Medical Science Co., Ltd. Overview
Industry: Biotechnology
Sector: Healthcare
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
AnPac Bio-Medical Science Co., Ltd. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review AnPac Bio-Medical Science Co., Ltd. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
AnPac Bio-Medical Science Co., Ltd. Competitors
AnPac Bio-Medical Science Co., Ltd. operates in the Biotechnology industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans